HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erika Ritter Selected Research

Therapeutic Uses

9/2010Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erika Ritter Research Topics

Disease

22Neoplasms (Cancer)
02/2024 - 09/2006
18Testicular Neoplasms (Testicular Cancer)
11/2013 - 03/2004
9Melanoma (Melanoma, Malignant)
03/2016 - 12/2007
4Ovarian Neoplasms (Ovarian Cancer)
11/2013 - 03/2010
3Disease Progression
01/2023 - 01/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2009 - 03/2004
2Prostatic Neoplasms (Prostate Cancer)
11/2013 - 02/2012
2Synovial Sarcoma (Synovioma)
01/2013 - 12/2007
2Fowlpox
09/2006 - 07/2003
1Breast Neoplasms (Breast Cancer)
02/2024
1Malignant Mesothelioma
01/2023
1Hypersensitivity (Allergy)
01/2013
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2013
1Fatigue
12/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2012
1Injection Site Reaction
12/2012
1Fever (Fevers)
10/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2012
1Triple Negative Breast Neoplasms
01/2012
1Skin Neoplasms (Skin Cancer)
09/2010
1Basal Cell Carcinoma (Rodent Ulcer)
07/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2010
1Hodgkin Disease (Hodgkin's Disease)
02/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2010
1Multiple Myeloma
01/2010
1Vaccinia
09/2006
1Lung Neoplasms (Lung Cancer)
03/2004
1Human Influenza (Influenza)
07/2003

Drug/Important Bio-Agent (IBA)

20AntigensIBA
11/2013 - 07/2003
11Proteins (Proteins, Gene)FDA Link
11/2013 - 03/2004
6IpilimumabIBA
02/2024 - 12/2008
6VaccinesIBA
12/2012 - 03/2004
5Cancer VaccinesIBA
02/2012 - 03/2004
4Monoclonal AntibodiesIBA
01/2023 - 12/2008
4AntibodiesIBA
11/2013 - 02/2010
3Peptides (Polypeptides)IBA
11/2013 - 07/2003
3Neoplasm Antigens (Tumor Antigens)IBA
10/2011 - 02/2009
2Differentiation AntigensIBA
03/2016 - 09/2010
2Biomarkers (Surrogate Marker)IBA
11/2013 - 02/2009
2AutoantibodiesIBA
11/2013 - 03/2010
2poly ICLCIBA
11/2013 - 12/2012
2AutoantigensIBA
12/2012 - 02/2009
2CTLA-4 AntigenIBA
10/2011 - 12/2008
2Immunoglobulin G (IgG)IBA
01/2011 - 03/2010
2ProteomeIBA
03/2010 - 02/2009
2Recombinant ProteinsIBA
02/2010 - 03/2004
1Immune Checkpoint InhibitorsIBA
02/2024
1NivolumabIBA
02/2024
1avelumabIBA
01/2023
1B7-H1 AntigenIBA
01/2023
1gag Gene Products (gag Protein)IBA
11/2013
1Monatide (IMS 3015)IBA
11/2013
1Antigen-Antibody Complex (Immune Complex)IBA
01/2013
1Fluorouracil (Carac)FDA LinkGeneric
01/2013
1CytokinesIBA
10/2012
1Bacterial VaccinesIBA
10/2012
1pullulanIBA
02/2012
1CholesterolIBA
02/2012
1Messenger RNA (mRNA)IBA
01/2012
1Therapeutic UsesIBA
09/2010
1Monophenol Monooxygenase (Tyrosinase)IBA
09/2010
1Vaccine AdjuvantsIBA
07/2008
1Imiquimod (Aldara)FDA LinkGeneric
07/2008
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2007
1NucleoproteinsIBA
07/2003
1EpitopesIBA
07/2003

Therapy/Procedure

5Immunotherapy
12/2012 - 12/2007
4Therapeutics
01/2023 - 02/2009
3Radiotherapy
01/2023 - 09/2010
2Drug Therapy (Chemotherapy)
01/2013 - 09/2010
1Cryosurgery
02/2024